Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 135
- 试验地点
- 1
- 主要终点
- Procedure Duration
研究概览
简要总结
Comparison of propofol and sevoflurane as a primary anesthetic for cardiac ablation of atrial fibrillation
详细描述
A side effect of some volatile anesthetics, such as isoflurane and desflurane, is enhanced automaticity, accounting for secondary atrial pacemakers. Volatile anesthetics also have varying effects on the AV node and His-Pukinje system. These agents also prolong the QT interval and, for this reason, volatile anesthetics as a group have at times been avoided for atrial fibrillation ablation due to the fear that they may affect the efficacy of the ablation and increase recurrence. However, sevoflurane does not have the effects shown for other volatile anesthetics cardiac conduction. At this point there has not been a study comparing propofol, a non volatile anesthetic typically used in these cases, to sevoflurane, a volatile anesthetic, to determine if volatile anesthetics should be avoided during these procedures. This study will challenge the existing belief that sevoflurane increases the length of time to ablate atrial fibrillation and also decreases the efficacy of the ablation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •have paroxysmal atrial fibrillation
- •undergoing their first ablation.
排除标准
- 未提供
研究组 & 干预措施
propofol
Participants receiving propofol as anesthetic for cardiac ablation.
干预措施: propofol (Drug)
sevoflurane
Participants receiving sevoflurane as anesthetic for cardiac ablation.
干预措施: sevoflurane (Drug)
结局指标
主要结局
Procedure Duration
时间窗: 1 day
The duration of the procedure in minutes.
Time to Extubation
时间窗: Procedure end time to time of extubation
The time from procedure end to the time the patient is extubated, in minutes. A longer extubation time is a worse outcome.
次要结局
未报告次要终点
研究者
George Guldan
Principal Investigator
Medical University of South Carolina
